The Global Veterinary Antimicrobial Susceptibility Testing Market Size is valued at 111.83 million in 2023 and is predicted to reach 181.37 million by the year 2031 at a 6.31% CAGR during the forecast period for 2024-2031.
Government efforts that are expanding and strict regulatory requirements are anticipated to fuel market expansion during the forecasted period. For instance, new EU regulations would outlaw routine antibiotic usage in agriculture starting in 2022. The COVID-19 pandemic's effect on the market has been negligible. Yet, the need for antibiotic susceptibility testing kits has significantly decreased due to fewer veterinary visits during the lockdown. Throughout the first two quarters of 2020, the demand for livestock goods and animal protein has also reduced. Vet visits recovered, and the market displayed a V-shaped recovery, supporting the increase. The U.S. clinic visit rate climbed by 6% in Q4 2020, according to IDEXX, which is anticipated to drive revenue growth during the forecast year.
The number of antimicrobials used in food animals will rise from 63,151 tonnes to 105,596 tonnes globally by 2030, predicts the OECD. A kilogram of beef requires about 45 milligrams of antimicrobials to produce. Furthermore, 1 kilogram of chicken receives 148 mg of antimicrobials. Accordingly, China, the U.S., Brazil, India, and Germany are the top 5 countries for antimicrobial consumption. For instance, in the United States in 2019, eating animals accounted for over 80% of the annual use of antimicrobials.
The Veterinary Antimicrobial Susceptibility Testing market is segmented by animal type, product, and end-use. The market is segregated into livestock and companion animals based on animal type. The market is segmented by product: Disks & Plates, Culture Media, Accessories & Consumables, and Automated AST Instruments. By end use, the market is segmented as Veterinary Reference Lab, Veterinary Research Institutes, and Others.
Over the projection period, the companion animal segment is anticipated to experience significant expansion. The demand for immunizations for companion animals is driven by the rise in pet ownership. The Pet Food Manufacturers Association estimates that 12 million pets will be owned by 41% of households in the United Kingdom by the year 2020. The Canadian Veterinary Medical Association estimates that as of 2020, there were, respectively, 8.1 million and 7.7 million households with cats and dogs. Amoxicillin-clavulanate is the antibacterial drug most frequently prescribed for use in companion animals. Antimicrobial susceptibility testing is in high demand due to the worrisome rise in the transmission of resistance from dogs and cats to people.
Due to the high volume of samples tested at these institutions, veterinary reference labs held the biggest revenue share. To support pet owners, farmers, government-related programmes, or research collaborations, these laboratories use diagnostic kits that are readily available on the market. The antimicrobial susceptibility tests (ASTs) might offer crucial data to choose the best antimicrobials for a particular treatment. Antimicrobial drugs in animals will be used less frequently as a result.
Due to the existence of significant industry participants, North America accounted for the second-largest share. According to the FDA, the use of antibiotics to promote farm animal growth was prohibited in the United States as of 2017. The USDA's Food Safety and Inspection Service (FSIS) runs a monitoring programme to ensure that antibiotics are successfully eliminated from animals before slaughter. Also, more veterinarians and animal healthcare facilities are expected to expand the market. For instance, the AVMA report states that there were 116,091 veterinarians in the nation in 2019; however, in 2020, there were 118,624 veterinarians in the nation.
| Report Attribute | Specifications |
| Market size value in 2023 | USD 111.83 mn |
| Revenue forecast in 2031 | USD 181.37 mn |
| Growth rate CAGR | CAGR of 6.31% from 2024 to 2031 |
| Quantitative units | Representation of revenue in US$ Million, and CAGR from 2024 to 2031 |
| Historic Year | 2019 to 2023 |
| Forecast Year | 2024-2031 |
| Report coverage | The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
| Segments covered | Animal Type, Product, And End-Use |
| Regional scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
| Competitive Landscape | BioMérieux SA; Becton, Dickinson and Company; Synbiosis; Thermo Fisher Scientific; Bruker Corporation; Danaher Corporation; Condalab; Bioguard Corporation; LiofilchemS.r.l.; HiMedia Laboratories; Bio-Rad Laboratories; Neogen Corporation. |
| Customization scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and available payment methods | Explore pricing alternatives that are customized to your particular study requirements. |
Veterinary Antimicrobial Susceptibility Testing Market By Animal Type-
Veterinary Antimicrobial Susceptibility Testing Market By Product-
Veterinary Antimicrobial Susceptibility Testing Market By End Use-
Veterinary Antimicrobial Susceptibility Testing Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.